Immunocompromised patients with SARS-CoV-2 infection in intensive care units, outcome and mortality
Open Access
- 17 August 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Clinical Intensive Care and Medicine
- Vol. 6 (1), 021-025
- https://doi.org/10.29328/journal.jcicm.1001036
Abstract
Background: The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak severely hit Northeastern France from March to May 2020. The massive arrival of SARS-CoV-2 positive patients in the intensive care units (ICU) raised the question of how immunocompromised patients would be affected. Therefore, we analyzed the clinical, biological and radiological features of 24 immunocompromised ICU patients with severe SAR-CoV-2 infection. Results: The mortality rate was significantly higher for immunocompromised patients compared with other patients (41.7% versus 27.3%, respectively, p = 0.021). Mortality occurred in the first 2 weeks of intensive care, highlighting the possible interest in prolonged full-code managnement of these patients. Finally, patients with lymphoid malignancies appeared to be particularly affected, mostly with monoclonal gamma-pathology. Conclusion: Mortality rate of SARS-CoV-2 acute respiratory syndrome in immuno-compromised patient is high. No treatment was associated with survival improvement. Prolonged full-code management is required for these patients.Keywords
This publication has 13 references indexed in Scilit:
- COVID-19 in Immunocompromised Hosts: What We Know So FarClinical Infectious Diseases, 2020
- Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemiaBritish Journal of Haematology, 2020
- The outbreak of COVID-19 in MulhouseAnnals of Intensive Care, 2020
- COVID-19 outcomes in patients with hematologic diseaseBone Marrow Transplantation, 2020
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Influenza and associated co-infections in critically ill immunosuppressed patientsCritical Care, 2019
- Acute respiratory failure in immunocompromised adultsThe Lancet Respiratory Medicine, 2018
- The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre studyIntensive Care Medicine, 1999
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993